Zoetis (ZTS) Net Cash Flow (2012 - 2026)
Zoetis' (ZTS) quarterly Net Cash Flow came in at -$526.0 million in Q1 2026, down 44.11% year-on-year from -$941.1 million in Q1 2025, and down 326.72% on a QoQ basis from $232.0 million in Q4 2025.
Zoetis (ZTS) Net Cash Flow (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Net Cash Flow data on file, last reported at -$526.0 million in Q1 2026.
- On a quarterly basis, Net Cash Flow fell 44.11% year-over-year to -$526.0 million in Q1 2026; TTM through Mar 2026 was $125.0 million, a 138.23% increase from a year earlier, with the FY2025 full-year figure at $286.0 million, up 1400.0% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$526.0 million, down from $232.0 million in the prior quarter.
- Over the last five years, Net Cash Flow for ZTS reached as high as $1.1 billion in Q4 2022 and fell as low as -$1.5 billion in Q1 2023.
- Historically, Net Cash Flow has averaged -$98.2 million across 5 years, with a median of -$127.0 million in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 385.65% in 2022 and fell as far as 17600.0% in 2022.
- Year by year, Net Cash Flow stood at $1.1 billion in 2022, then tumbled by 73.22% to $290.0 million in 2023, then declined by 1.38% to $286.0 million in 2024, then fell by 18.88% to $232.0 million in 2025, then slumped by 326.72% to -$526.0 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$526.0 million in Q1 2026, $232.0 million in Q4 2025, and $644.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 15.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -526.00 Mn |
| Mar 31, 2026 | -526.00 Mn |
| Dec 31, 2025 | 232.00 Mn |
| Dec 31, 2025 | 232.00 Mn |
| Sep 30, 2025 | 644.00 Mn |
| Sep 30, 2025 | 644.00 Mn |
| Jun 30, 2025 | -225.00 Mn |
| Jun 30, 2025 | -225.00 Mn |
| Mar 31, 2025 | -365.00 Mn |
| Mar 31, 2025 | -365.00 Mn |
| Dec 31, 2024 | 286.00 Mn |
| Dec 31, 2024 | 286.00 Mn |
| Sep 30, 2024 | 145.00 Mn |
| Sep 30, 2024 | 145.00 Mn |
| Jun 30, 2024 | -393.00 Mn |
| Jun 30, 2024 | -393.00 Mn |
| Mar 31, 2024 | -60.00 Mn |
| Mar 31, 2024 | -60.00 Mn |
| Dec 31, 2023 | 290.00 Mn |
| Dec 31, 2023 | 290.00 Mn |